Trial
NCT06710197
IL-1 Inhibition in Early TNBC
Phase IIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
University Health Network, Toronto
Collaborators
—
Condition
Early Stage Triple Negative ER Low Breast Cancer
Intervention
Anakinra (Kineret®)
Why stopped
Terminated with sponsor-investigator agreement due to extended period without enrollment and the absence of foreseeable participant accrual. No participants were enrolled.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-03-05